Cresset Asset Management, LLC Staar Surgical CO Transaction History

Cresset Asset Management, LLC

  • $25.6 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$70.55 - $111.58 $493 - $781
-7 Reduced 0.07%
10,665 $753,000
Q2 2022

Aug 15, 2022
BUY
$50.24 - $80.48 $100,680 - $161,281
2,004 Added 23.12%
10,672 $757,000
Q1 2022

May 16, 2022
BUY
$57.98 - $93.5 $115,612 - $186,439
1,994 Added 29.88%
8,668 $693,000
Q4 2021

Feb 10, 2022
BUY
$88.02 - $127.79 $92,068 - $133,668
1,046 Added 18.59%
6,674 $610,000
Q2 2021

Aug 10, 2021
BUY
$105.76 - $154.96 $595,217 - $872,114
5,628 New
5,628 $858,000

Others Institutions Holding STAA

# of Institutions
251
Shares Held
47.3M
Call Options Held
427K
Put Options Held
206K
View Full List

About STAAR SURGICAL CO

STAA Quotes by TradingView
  • Ticker STAA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 48,038,300
  • Market Cap $1.11B
  • Description
  • STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...
More about STAA
Track This Portfolio

Track Cresset Asset Management, LLC Portfolio

Follow Cresset Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cresset Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email